Kathelijn Fischer

Pediatric Hematologist
Centre for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
Utrecht, Utrecht, Netherlands

Presentation(s):

• OC 01.4 - Interim analysis of joint outcomes in adult and adolescent patients with severe hemophilia A receiving efanesoctocog alfa during the phase 3 XTEND-ed long-term extension study

  Saturday, June 22, 2024
  13:45 – 14:00 ICT

• PB0525 - Real-world Bleeding Rates on Emicizumab using Digital Treatment Diary data

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• Panel Discussion

  Tuesday, June 25, 2024
  13:12 – 13:25 ICT

• PB1184 - A survey of clinical practice of laboratory monitoring and management of bleeding in children on emicizumab prophylaxis in the PedNet centers

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 61.2 - Determinants of successful immune tolerance induction in people with severe hemophilia A

  Tuesday, June 25, 2024
  15:00 – 15:15 ICT

• OC 71.2 - Intracranial hemorrhage before the initiation of prophylaxis in early age in hemophilia A – data from the PedNet registry

  Wednesday, June 26, 2024
  10:30 – 10:45 ICT